Found: 9
Select item for more details and to access through your institution.
Exploring Natural Product Activity and Species Source Candidates for Hunting ABCB1 Transporter Inhibitors: An In Silico Drug Discovery Study.
- Published in:
- Molecules, 2022, v. 27, n. 10, p. 3104, doi. 10.3390/molecules27103104
- By:
- Publication type:
- Article
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M pro) Inhibitors.
- Published in:
- Molecules, 2021, v. 26, n. 7, p. 2082, doi. 10.3390/molecules26072082
- By:
- Publication type:
- Article
Non- β -Lactam Allosteric Inhibitors Target Methicillin-Resistant Staphylococcus aureus : An In Silico Drug Discovery Study.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 8, p. 934, doi. 10.3390/antibiotics10080934
- By:
- Publication type:
- Article
SuperNatural inhibitors to reverse multidrug resistance emerged by ABCB1 transporter: Database mining, lipid-mediated molecular dynamics, and pharmacokinetics study.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0288919
- By:
- Publication type:
- Article
Pyronaridine as a Bromodomain-Containing Protein 4- N -Terminal Bromodomain (BRD4-BD1) Inhibitor: In Silico Database Mining, Molecular Docking, and Molecular Dynamics Simulation.
- Published in:
- Molecules, 2023, v. 28, n. 15, p. 5713, doi. 10.3390/molecules28155713
- By:
- Publication type:
- Article
In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28226-7
- By:
- Publication type:
- Article
In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28226-7
- By:
- Publication type:
- Article
In-Silico Mining of the Toxins Database (T3DB) towards Hunting Prospective Candidates as ABCB1 Inhibitors: Integrated Molecular Docking and Lipid Bilayer-Enhanced Molecular Dynamics Study.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 7, p. 1019, doi. 10.3390/ph16071019
- By:
- Publication type:
- Article
Chetomin, a SARS-CoV-2 3C-like Protease (3CL pro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 1, p. 250, doi. 10.3390/v15010250
- By:
- Publication type:
- Article